Combined interferon/antiestrogen therapy for treatment of breast

Details Combined interferon/antiestrogen therapy for treatment of breast Combined interferon/antiestrogen therapy for treatment of breast

1989-05-30

1991-06-18

Friedman, Stanley J.

Drug, bio-affecting and body treating compositions

Lymphokine

Interferon

A61K 3766

Patent

active

050248332

ABSTRACT:
Proliferation of breast cancer is treated by a combined type I interferon/antiestrogen therapy. Preferably artiestrogen treatment is sequential to treatment with interferon.

REFERENCES:
Abstracts of 1985 TNO-ISIR meeting on Interferon System on Oct. 13-18, 1985, Sica et al., "Proliferative Effect of Beta-Interferon (Frone) Alone or Combined With Tamoxifen (TAM) in Breast Cancer Cells".
Van Den Berg et al., Br J Cancer 52 (3) (3/1985) p. 428.
Sica et al., Anticancer res. 6 (3 Part A) (4/1986) p. 396.

Affiliated with

Also associated with

Rating

Combined interferon/antiestrogen therapy for treatment of breast does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combined interferon/antiestrogen therapy for treatment of breast, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combined interferon/antiestrogen therapy for treatment of breast will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-144738